AnGes, Inc. (TYO:4563)
25.00
+1.00 (4.17%)
Nov 18, 2026, 10:12 AM JST
AnGes Market Cap
AnGes has a market cap or net worth of 10.13 billion as of November 17, 2026. It is the 28,077th most valuable company in the world and the 2,465th biggest in Japan. Its market cap has decreased by 65.02% in one year.
Market Cap
10.13B
Enterprise Value
12.07B
Revenue
979.00M
Global Rank
Country Rank
#2,465 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since September 25, 2002, AnGes's market cap has decreased from 23.36B to 10.13B, a decrease of -56.64%. That is a compound annual growth rate of -3.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 10.13B | -57.15% |
| Dec 30, 2025 | 23.64B | 57.68% |
| Dec 30, 2024 | 14.99B | 5.37% |
| Dec 29, 2023 | 14.23B | -31.96% |
| Dec 30, 2022 | 20.91B | -64.42% |
| Dec 30, 2021 | 58.78B | -64.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CanBas | 13.15B |
| ReproCELL | 11.32B |
| Immuno-Biological Laboratories | 8.34B |
| Kubota Pharmaceutical Holdings | 7.95B |
| K Pharma,Inc. | 7.85B |
| StemRIM | 7.77B |
| Carna Biosciences | 7.25B |
| Kidswell Bio | 7.14B |